                         SEQUENCE LISTING

<110>  Osmulski, Pawel A
       Gaczynksa, Maria
       Pickering, Andrew
       Karpowicz, Przemyslaw
       Jankowska, Elzbieta
 
<120>  Peptide-based Compositions and Methods for Treating Alzheimer's 
       Disease

<130>  21105.0073P1

<150>  US 62/900,217
<151>  2019-09-13

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  1

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Ser 
1               5                   10          


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  2

Lys Asp Glu Gln Glu His Glu Phe Tyr Lys 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Tic-d-Oic

<400>  3

Gly Arg Lys Lys Arg Arg Gln Arg Pro Ser 
1               5                   10  


<210>  4
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  alpha-aminoisobutyric acid

<400>  4

Gly Arg Lys Lys Arg Arg Gln Gly Arg Pro Ser 
1               5                   10      


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  alpha-aminoisobutyric acid

<400>  5

Gly Arg Lys Lys Arg Arg Gln Gly Gln Arg Arg Lys Lys Arg Gly 
1               5                   10                  15  


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  3,5-diaminobenzoic acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  3,5-diaminobenzoic acid; and 3,5-diaminobenzoic acid can be 
       attached to KKK

<400>  6

Lys Lys Lys Lys Lys Lys 
1               5       


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  7

Gly Arg Lys Lys Arg Arg Gln Ala Ala Ala Pro Ser 
1               5                   10          


<210>  8
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  8

Gly Arg Lys Lys Arg Arg Gln 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  9

Arg Gln Arg Arg Arg Pro Ser 
1               5           


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  10

Gln Glu Gly Thr Pro Glu Gly Leu Tyr Leu 
1               5                   10  


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  11

Lys Asp Glu Gln Glu His Glu Phe Tyr Lys 
1               5                   10  


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  12

Lys Lys Lys Ala Asn Leu Gln Tyr Tyr Ala 
1               5                   10  


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  13

Lys Asn Met Ser Ile Lys Lys Leu Trp Lys 
1               5                   10  


<210>  14
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  succinyl

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  7-amino-4-methylcoumarin

<400>  14

Leu Leu Val Tyr 
1               


<210>  15
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  L-1,2,3,4-tetrahydroisoquinoline -3-carboxylic acid covalently 
       attached to Octahydroindole-2-carboxylic acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  is covalently attached to Octahydroindole-2-carboxylic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Tic D-Oic is between residue 5 and residue 6

<400>  15

Gly Arg Lys Arg Gln Arg Pro Ser 
1               5               


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tic-Oic is between residue 3 and residue 4

<400>  16

Gly Arg Lys Arg Gln Arg Arg Arg Pro Ser 
1               5                   10  


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Tic-Oic is between residue 7 and 8

<400>  17

Gly Arg Lys Lys Arg Arg Gln Arg Pro Ser 
1               5                   10  


<210>  18
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tic-Oic is between residues 3 and 4

<400>  18

Lys Lys Lys Lys Lys Lys 
1               5       


<210>  19
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tic-Oic is between residues 3 and 4

<400>  19

Ala Ala Ala Ala Ala Ala 
1               5       


